Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome Syndrome

4. maj 2026 opdateret af: Riphah International University

Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome

The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Symptoms persisting for more than 6 weeks (subacute or chronic cases).
  • Sedentary to moderately active individuals (i.e., not involved in heavy gluteal-strengthening or core training for at least 3 months prior to the study). vParticipants will be diagnosed with Dead Butt Syndrome based on the presence of at least two out of three of the following criteria:
  • Self-reported dull ache, discomfort, or tightness in the gluteal region worsened with prolonged sitting or walking.
  • Positive Trendelenburg Test
  • ≤ 4/5 on the standard MRC grading scale

Exclusion Criteria:

  • Pregnancy or plans to become pregnant during the study period.
  • Diagnosed hip labral tears, piriformis syndrome, or sciatica unrelated to gluteal amnesia.
  • Degenerative or neurological conditions such as osteoarthritis, multiple sclerosis, stroke, or spinal cord injury.
  • History of significant spinal trauma or surgery in the past 12 months.
  • Engagement in regular physical exercise or participation in rehabilitation programs within the last 6 months.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Group A: Gluteal Activation
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.
Aktiv komparator: Active comparator
Group B - Gluteal Muscle Activation Program + Core Strengthening Program Hot pack applied to lumbar area for 15-20 minutes. 3 sessions per week for 4 weeks. Moderate intensity, bodyweight-based exercises with controlled movement. Each exercise: 3 sets of 15 repetitions with 30-40 seconds rest between sets. Target: Gluteal muscles and pelvic control:
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.Core Strengthening focuses on stabilizing the spine and pelvis by targeting the abdominals, back, and deep pelvic muscles.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Tampa Scale of Kinesiophobia (TSK-11)
Tidsramme: 4 weeks
The Tampa Scale for Kinesiophobia (TSK-11) is a shortened, 11-item version of the original 17-item TSK questionnaire used to assess fear of movement, or kinesiophobia, in individuals with chronic pain or other conditions involving movement limitations
4 weeks
Lower Extremity Functional Scale (LEFS)
Tidsramme: 4 weeks
The Lower Extremity Functional Scale (LEFS) is used to assess "patients' initial function, ongoing progress, and outcome" for a variety of disorders affecting the lower extremities. LEFS is a self-reported survey. The LEFS total score ranges from 0 to 80, with higher scores indicating better functional ability.
4 weeks
Numeric Pain Rating Scale
Tidsramme: 4 Weeks
The Numeric Pain Rating Scale (NPRS) is a tool used to measure the intensity of pain. It's a unidimensional scale, typically an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable. Patients verbally or numerically indicate the level of pain they are experiencing.
4 Weeks
The Trendelenburg test
Tidsramme: 4 Weeks
The Trendelenburg test is a physical examination used to assess the strength of hip abductor muscles, specifically the gluteus medius and gluteus minimus, or to check for the competency of venous valves in the legs. A positive Trendelenburg sign, indicated by a drop of the pelvis on the unsupported side during a single-leg stance, suggests weakness in the hip abductors.
4 Weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Attiq Ur Rehman, MS, Riphah International University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

5. december 2025

Primær færdiggørelse (Anslået)

5. maj 2026

Studieafslutning (Anslået)

28. maj 2026

Datoer for studieregistrering

Først indsendt

4. maj 2026

Først indsendt, der opfyldte QC-kriterier

4. maj 2026

Først opslået (Faktiske)

8. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

8. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

4. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • REC/02289 Rehmat

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Syndrom

Kliniske forsøg med Group A: Gluteal Muscle Activation

Abonner